Log in or Sign up for Free to view tailored content for your specialty!
Neurology News
Study: No clear association between pet ownership and brain, heart health
ORLANDO, Fla. — An analysis of a large cohort of individuals enrolled in a continuous, multinational survey found no clear associations between brain and heart health and pet ownership, according to a poster.
Q&A: New Alzheimer’s dataset allows ‘whispers from the brain’ to assist in early detection
The future of Alzheimer’s disease detection and treatment may lie in AI-based datasets encompassing an abundance of real-world evidence from a large number of patients, an expert said.
Log in or Sign up for Free to view tailored content for your specialty!
Tea, red wine among foods tied to lower risk for dementia
Adults who more frequently consumed several flavonoid-rich foods, like berries and tea, had a significantly lower risk for dementia, according to an analysis published in JAMA Network Open.
Gender, sexual identity may be associated with brain health outcomes
LGBTQ+ people may be more likely to experience adverse brain health outcomes, including late-life depression and dementia, compared with cisgender straight people, according to study results published in Neurology.
MIND diet may reduce the risk for cognitive decline
Higher adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay, or MIND) diet reduced the risk for cognitive impairment, particularly in women, results from a cohort study published in Neurology showed.
VIDEO: More data support first FDA-approved drug to treat Alzheimer’s-related agitation
PHILADELPHIA — In this Healio Video Perspective from the Alzheimer’s Association International Conference, Johan Luthman, PhD, discusses new data from post hoc analyses evaluating the efficacy of Rexulti for Alzheimer’s-related agitation.
One in three former professional football players believe they have CTE
Around one-third of former professional football players perceived themselves as having chronic traumatic encephalopathy, according to results from a cross-sectional study published in JAMA Neurology.
FDA approves second Niemann-Pick disease type C treatment
The FDA has approved Aqneursa as an oral treatment for neurological symptoms associated with Niemann-Pick disease type C, a rare genetic disease, in adults and children weighing at least 15 kg, according to a press release.
Diabetes drug linked to reduced risk for dementia, Parkinson’s disease
The use of sodium-glucose cotransporter 2 inhibitors reduced the risk for multiple neurodegenerative diseases in adults with type 2 diabetes, according to study results published in Neurology.
FDA approves Miplyffa for Niemann-Pick disease type C
The FDA announced in a press release that it has approved Miplyffa to treat neurological symptoms associated with Niemann-Pick disease type C in patients aged 2 years and older.
-
Headline News
Crisis pregnancy center practices suggest ‘need for greater scrutiny’
December 03, 20243 min read -
Headline News
FDA investigating hematologic cancer risk in kids treated with Skysona for brain disease
December 02, 20242 min read -
Headline News
Fear of recurrence consistent source of stress for heart attack survivors
December 03, 20242 min read
-
Headline News
Crisis pregnancy center practices suggest ‘need for greater scrutiny’
December 03, 20243 min read -
Headline News
FDA investigating hematologic cancer risk in kids treated with Skysona for brain disease
December 02, 20242 min read -
Headline News
Fear of recurrence consistent source of stress for heart attack survivors
December 03, 20242 min read